Results reported as positive, negative or not 5, 10 Methylene Tetra Diagnosis/ done. Measure of enzyme Supplemental Hydrofolate Reductase Safety which metabolizes homocysteine. Measured in seconds. Activated Partial Detects abnormalities in Diagnosis/ Thromboplastin Time Supplemental blood clotting and anti- Safety (aPTT) coagulants. Results reported as positive, negative or not done. Disorder Activated Protein C characterized by poor Diagnosis Supplemental Resistance anticoagulant response to activated protein C; acquired or inherited. Results reported as positive, negative or not Ammonia Safety Supplemental done. Quantitative ammonia level. Results reported as Anti-CardiolipinAb, IgG, positive, negative or not Diagnosis Supplemental IgM done; measured in U/mL Results reported as Diagnosis/ Anti-ds DNA Ab positive, negative or not Supplemental Safety done; measured in U/mL Results reported as Diagnosis/ Anti-ENA/ ANA Screen positive, negative or not Supplemental Safety done; measured in U/mL Results reported as Diagnosis/ Anti-HAV Hepatitis positive, negative or not Supplemental Safety done; measured in U/mL Results reported as Anti-HCA Hepatitis positive, negative or not Safety Supplemental done; measured in U/mL Results reported as Anti-HCB Hepatitis positive, negative or not Safety Supplemental done; measured in U/mL Results reported as Anti-HCV Hepatitis positive, negative or not Diagnosis Supplemental done; measured in U/mL Antibodies to HIV-1 and HIV-2, usually by ELISA; results reported as Diagnosis/ Anti-HIV Ab positive, negative or not Supplemental Safety done; positive result should be confirmed by Western Blot
5, 10 Methylene Tetra Hydrofolate Reductase Results reported as positive, negative or not done. Measure of enzyme which metabolizes homocysteine. Diagnosis/ Safety Supplemental Activated Partial Thromboplastin Time (aPTT) Measured in seconds. Detects abnormalities in blood clotting and anti- coagulants. Diagnosis/ Safety Supplemental Activated Protein C Resistance Results reported as positive, negative or not done. Disorder characterized by poor anticoagulant response to activated protein C; acquired or inherited. Diagnosis Supplemental Ammonia Results reported as positive, negative or not done. Quantitative ammonia level. Safety Supplemental Anti-CardiolipinAb, IgG, IgM Results reported as positive, negative or not done; measured in U/mL Diagnosis Supplemental Anti-ds DNA Ab Results reported as positive, negative or not done; measured in U/mL Diagnosis/ Safety Supplemental Anti-ENA/ ANA Screen Results reported as positive, negative or not done; measured in U/mL Diagnosis/ Safety Supplemental Anti-HAV Hepatitis Results reported as positive, negative or not done; measured in U/mL Diagnosis/ Safety Supplemental Anti-HCA Hepatitis Results reported as positive, negative or not done; measured in U/mL Safety Supplemental Anti-HCB Hepatitis Results reported as positive, negative or not done; measured in U/mL Safety Supplemental Anti-HCV Hepatitis Results reported as positive, negative or not done; measured in U/mL Diagnosis Supplemental Anti-HIV Ab Antibodies to HIV-1 and HIV-2, usually by ELISA; results reported as positive, negative or not done; positive result should be confirmed by Western Blot Diagnosis/ Safety Supplemental
F1287_Laboratory_Test_Recommendations.docx